In addition, some compounded GLP-1s come in different concentrations than the standard forms
By day 3 of the first injection, appetite is noticeably reduced
The clinical trial starting dose (1 mg/week) is already close to the community protocol (1.5 mg/week split 3x)
Research use only means in-vitro laboratory testing and controlled experimental protocols only
Thirty to forty-five minutes of compound movements, squats, deadlifts, presses, rows, done with progressive overload, is sufficient to meaningfully preserve lean mass during GLP-1 therapy
adults are considered obese, and with traditional weight loss strategies like diet and exercise proving insufficient for many, physicians are increasingly turning to medication as an adjunct treatment